• OPEN AN ACCOUNT
Indian Indices
Sensex
76,152.86 -417.49
( -0.55%)
Global Indices
Nasdaq
53,087.25 299.37
(0.57%)
Dow Jones
7,688.45 35.98
(0.47%)
Hang Seng
64,337.38 11.74
(0.02%)
Nikkei 225
10,831.87 75.42
(0.70%)
Forex
USD-INR
94.95 -0.29
(-0.30%)
EUR-INR
110.11 -0.38
(-0.35%)
GBP-INR
128.48 -0.52
(-0.40%)
JPY-INR
0.59 0.00
(-0.47%)

EQUITY - MARKET SCREENER

Marksans Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
524404
INE750C01026
36.4616629
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
MARKSANS
46.83
15067.69
EPS(TTM)
Face Value()
Div & Yield %
7.1
1
0.27
 

pakka ltd
Filtron Engineers reports consolidated net profit of Rs 2.87 crore in the March 2026 quarter
Jun 01,2026
Net profit of Filtron Engineers reported to Rs 2.87 crore in the quarter ended March 2026 as against net loss of Rs 0.01 crore during the previous quarter ended March 2025. Sales reported to Rs 65.12 crore in the quarter ended March 2026. There were no Sales reported during the previous quarter ended March 2025.

For the full year,net profit reported to Rs 4.15 crore in the year ended March 2026 as against net loss of Rs 0.30 crore during the previous year ended March 2025. Sales rose 30328.00% to Rs 76.07 crore in the year ended March 2026 as against Rs 0.25 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales65.120 0 76.070.25 30328
OPM %3.640 -4.90-160.00 -
PBDT2.910.02 14450 4.29-0.17 LP
PBT2.87-0.01 LP 4.15-0.30 LP
NP2.87-0.01 LP 4.15-0.30 LP